<?xml version="1.0" encoding="utf-8"?>
<items><story><date>02:10 03 January 2007 (UTC)</date><text>BRUSSELS Jan 3 Belgian biotechnology company
Galapagos GLPG.BR(GLPG.AS) has extended its drug discovery
collaboration with U.S. group Amgen (AMGN.O), it said on
Wednesday. Galapagos said it would receive an upfront fee of $2.4
million as a payment for 2007 research costs and that it would
also receive payment in the form of library and technology
access fees, research fees, milestone payments and bonuses.


</text><link>http://www.reuters.com/article/2007/01/03/galapagos-amgen-idUSL039263520070103</link><sectors></sectors><title>biotechs galapagos , amgen extend collaboration</title></story></items>